A health worker carries out an olfactory test to monitor smell loss to a resident 65 km from Buenos Aires city, on May 24, 2020, amid the COVID-19 coronavirus pandemic.
ALEJANDRO PAGNI/AFP via Getty Images
Many respiratory viruses cause us to temporarily lose our sense of smell. But SARS-CoV-2 isn’t like those other viruses. Researchers are now exploring how it differs and whether patients recover.
If you’re itching to get back to the gym when it re-opens, here’s what you can do to protect yourself and others from COVID-19.
It takes a tremendous amount of computing power to simulate all the components and behaviors of viruses and cells.
Copyright: Thomas Splettstoesser scistyle.com
Scanning through billions of chemicals to find a few potential drugs for treating COVID-19 requires computers that harness together thousands of processors.
Researchers have been trying to understand a possible link between blood pressure medications and COVID-19.
(Shutterstock)
The use of antihypertension medication during the coronavirus pandemic has been a subject of hot debate but people should be cautious about simple conclusions.
Lagos state officials disinfecting roads in the state.
Shutterstock
A continuous lock down is detrimental to Nigeria’s large population of people living below poverty lines, but lifting the restrictions without a proper plan is equally dangerous. Here’s what to do.
Antibodies (pink) attacking a virus particle (blue).
STEVEN MCDOWELL/SCIENCE PHOTO LIBRARY
Antibodies that recognize and block SARS-CoV-2 infection have the potential to be powerful weapons. An infectious disease expert explains what antibodies are and how they could be used as a therapy.
An antigen test was given emergency use authorization by the FDA in early May. A biochemist explains how COVID-19 antigen tests work.
Pairing widespread testing with fast, effective contact tracing is considered essential for controlling the coronavirus’s spread as the U.S. passes 100,000 deaths.
AP Images/Rick Bowmer
Since the state’s first coronavirus case surfaced, trained case investigators have traced the contacts of every person who tested positive. Here’s what else South Carolina got right.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It’s based on a vaccine that was already in development for influenza, and has shown promise in animal studies.
It’s not yet clear whether antibodies in the blood of patients who have been infected with SARS-CoV-2 indicate immunity. Above: blood specimens for COVID-19 antibody tests.
(AP Photo/Mary Altaffer)
Thinking of SARS-CoV-2 as an invisible enemy with an evil personality and humanlike motivations is a natural offshoot of the way people evolved to anthropomorphize so as not to overlook threats.
Evidence on the efficacy of HCQ/CQ for COVID-19 is very limited at best or even stands on shaky grounds.
Manjurul Haque/Shuttestock
Drama on massive production and importation of HCQ/CQ throughout the world has once again served as a reminder that public policy must stand on solid scientific foundation.
You’re heading to your first post-COVID-19 dinner party. How many guests is too many? Are hugging and handshakes OK now? And most importantly, should you bring your own cutlery?
A researcher performs a CRISPR/Cas9 process at the Max-Delbrueck-Centre for Molecular Medicine in Germany .
Gregor Fischer/picture alliance via Getty Images
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
The US president has reignited controversy over the use of malaria drugs to guard against COVID-19. But there is little reliable evidence so far that this tactic is safe or effective.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand